Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
4.520
+0.005 (0.11%)
At close: Dec 5, 2025, 4:00 PM EST
4.510
-0.010 (-0.22%)
Pre-market: Dec 8, 2025, 4:10 AM EST
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $157.44 million as of December 8, 2025. Its market cap has decreased by -23.08% in one year.
Market Cap
157.44M
Enterprise Value
29.55M
1-Year Change
-23.08%
Ranking
Category
Stock Price
$4.52
Market Cap Chart
Since the IPO on February 21, 2018, Molecular Partners AG's market cap has decreased from $595.47M to $157.44M, a decrease of -73.56%. That is a compound annual growth rate of -15.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 157.44M | -4.58% |
| Dec 30, 2024 | 165.01M | 22.94% |
| Dec 29, 2023 | 134.22M | -38.09% |
| Dec 30, 2022 | 216.81M | -65.56% |
| Dec 30, 2021 | 629.47M | -8.03% |
| Dec 30, 2020 | 684.44M | 75.63% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |